We are live on ! Find out more
KAS

Kestra Advisory Services Portfolio holdings

AUM $31B
1-Year Est. Return 28.39%
This Fund
S&P 500
This Quarter Est. Return
-3.32%
1 Year Est. Return
+28.39%
3 Year Est. Return
+85.12%
5 Year Est. Return
+94.26%
10 Year Est. Return
AUM
$9.6B
AUM Growth
-$278M
Cap. Flow
+$167M
Cap. Flow %
1.74%
Top 10 Hldgs %
18.08%
Holding
2,166
New
162
Increased
953
Reduced
828
Closed
169

Sector Composition

Rank Sector Weight
1 Technology 10.89%
2 Financials 5.71%
3 Healthcare 4.78%
4 Consumer Discretionary 4.75%
5 Communication Services 3.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NAT icon
1976
Nordic American Tanker
NAT
$1.38B
$32K ﹤0.01%
15,124
-1,785
-11% -$3.17K
AMBR
1977
Amber International Holding Ltd
AMBR
$130M
$29K ﹤0.01%
+2,497
New +$71.5K
ROOT icon
1978
Root
ROOT
$857M
$26K ﹤0.01%
739
-55
-7% -$1.98K
FRSX
1979
Foresight Autonomous Holdings
FRSX
$3.9M
$22K ﹤0.01%
+154
New +$25.4K
TONX
1980
TON Strategy Co
TONX
$168M
$22K ﹤0.01%
3
COMS
1981
DELISTED
COMSovereign Holding Corp. Common Stock
COMS
$21K ﹤0.01%
250
ATHX
1982
DELISTED
Athersys, Inc. Common Stock
ATHX
$19K ﹤0.01%
1,263
+20
+2% +$418
MUX icon
1983
McEwen Inc
MUX
$1.03B
$17K ﹤0.01%
2,042
RMTI icon
1984
Rockwell Medical
RMTI
$28.4M
$17K ﹤0.01%
336
RNTX
1985
Rein Therapeutics
RNTX
$63.1M
$15K ﹤0.01%
1,500
NYMX
1986
DELISTED
Nymox Pharmaceutical Corp
NYMX
$15K ﹤0.01%
11,532
KALA icon
1987
KALA BIO
KALA
$14.1M
$14K ﹤0.01%
4
AIXC
1988
AIxCrypto Holdings Inc
AIXC
$13.4M
$13K ﹤0.01%
+40
New +$15.6K
PRQR icon
1989
ProQR Therapeutics
PRQR
$243M
$10K ﹤0.01%
10,500
CRBP icon
1990
Corbus Pharmaceuticals
CRBP
$166M
$8K ﹤0.01%
525
-117
-18% -$1.55K
ECOR icon
1991
electroCore
ECOR
$54.9M
$8K ﹤0.01%
904
TCRT icon
1992
Alaunos Therapeutics
TCRT
$4.59M
$8K ﹤0.01%
81
CALA
1993
DELISTED
Calithera Biosciences, Inc
CALA
$8K ﹤0.01%
1,000
DRRX
1994
DELISTED
DURECT Corp
DRRX
$7K ﹤0.01%
1,042
-12,349
-92% -$85.9K
ASXC
1995
DELISTED
Asensus Surgical, Inc.
ASXC
$7K ﹤0.01%
+11,539
New +$8.89K
GNLN icon
1996
Greenlane Holdings
GNLN
$1.22M
0
BIOL
1997
DELISTED
Biolase, Inc.
BIOL
$5K ﹤0.01%
+5
New +$4.61K
ACA icon
1998
Arcosa
ACA
$7.13B
-21,181
Closed -$1.12M
AI icon
1999
C3.ai
AI
$1.43B
-17,028
Closed -$532K
AMBA icon
2000
Ambarella
AMBA
$3.77B
-1,402
Closed -$284K

Similar funds

Kestra Advisory Services's Q1 2022 Portfolio in Review

As of Q1 2022, Kestra Advisory Services held 2,166 positions worth $9.6B, down 2.8% from $9.88B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Kestra Advisory Services's Q1 2022 filing shows 162 new, 953 increased, 828 reduced and 169 closed positions. Its largest new stake was FT Vest Growth-100 Buffer ETF March: 319,252 shares worth $7.24M. The largest sale was First Trust Smith Opportunistic Fixed Income ETF, an estimated $30.9M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.

  • Kestra Advisory Services's largest Q1 2022 buy was FT Vest Growth-100 Buffer ETF March: 319,252 shares worth $7.24M.
  • Kestra Advisory Services added most to First Trust Rising Dividend Achievers ETF in Q1 2022, an estimated $40M increase.
  • Kestra Advisory Services's biggest Q1 2022 reduction was First Trust Smith Opportunistic Fixed Income ETF, cutting an estimated $30.9M.
  • Kestra Advisory Services fully exited Shopify in Q1 2022, selling an estimated $14.3M.
  • Kestra Advisory Services's ten largest holdings make up 18% of its $9.6B portfolio in Q1 2022.
  • Kestra Advisory Services opened 162 new positions and closed 169 in Q1 2022.
  • Kestra Advisory Services's portfolio value fell 2.8% quarter-over-quarter to $9.6B.

Based on Kestra Advisory Services's 13F filing for Q1 2022, filed 26 Apr 2022.